Posttraumatic Stress Disorders Clinical Trial
— NETOfficial title:
A Randomized Control Trial of Narrative Exposure Therapy Versus Treatment as Usual in the Therapy of Borderline Personality Disorder
Verified date | October 2009 |
Source | Zentrum für Integrative Psychiatrie |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Definition of the efficacy of NET compared with "treatment as usual" in the treatment of patients with complex traumatic disease (borderline personality disorder (BPD) and posttraumatic stress disorder (PTSD)) as assessed by structured clinical interviews. Furthermore, to evaluate the sleep, cortisol level and epigenetic differences in the process of the specific therapy compared to treatment as usual.
Status | Unknown status |
Enrollment | 80 |
Est. completion date | October 2013 |
Est. primary completion date | October 2011 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - DSM-IV -TR Diagnosis axis II: borderline personality disorder; axis I: posttraumatic stress disorder - stable medication - age 18-45 years, gender female - legal competence - sufficient cognitive function - sufficient knowledge of the German or English language Exclusion Criteria: Known severe internal, neurological, musculoskeletal, endocrinological or sleep disorders with organic origin (clinical examination during the screening visit, judged by the investigator) - gravidity (positive ß-HCG test) - continuing and not interruptible exposure to sexual or physical abuse - acute suicidal tendency - positive drug-screening in urine toxicology test |
Country | Name | City | State |
---|---|---|---|
Germany | Zentrum Integrative Psychiatrie | Kiel |
Lead Sponsor | Collaborator |
---|---|
Zentrum für Integrative Psychiatrie | University of Konstanz |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinician-Administered PTSD Scale (CAPS) | 0 - 1 - 6 - 12 - 24 month | ||
Secondary | Borderline symptom checklist 23 (BSL) | 0 - 1 - 6 - 12 - 24 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00611871 -
The Use of Propranolol to Block Memory Reconsolidation in PTSD
|
Phase 2 | |
Completed |
NCT02057081 -
Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI
|
N/A | |
Completed |
NCT03684473 -
An Online CBT, Mindfulness Meditation & Yoga (CBT-MY) Intervention for Posttraumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT00965809 -
Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD)
|
Phase 4 | |
Completed |
NCT02774642 -
Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study)
|
N/A | |
Completed |
NCT01049516 -
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel
|
N/A | |
Completed |
NCT00105885 -
Telephone Care as a Substitute for Routine Psychiatric Medication
|
N/A | |
Completed |
NCT02556645 -
A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel
|
N/A | |
Recruiting |
NCT01743664 -
The Efficacy of EMDR in Patients With PTSD in Multiple Sclerosis
|
Phase 3 | |
Completed |
NCT01158001 -
Telemedicine for Improved Delivery of Psychosocial Treatments for Post Traumatic Stress Disorder
|
N/A | |
Completed |
NCT03997344 -
Veterans Nature Therapy (Vet Hike)
|
N/A | |
Completed |
NCT01605253 -
Eszopiclone for the Treatment of Posttraumatic Stress Disorder
|
Phase 4 | |
Not yet recruiting |
NCT02384369 -
Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder
|
Phase 2 | |
Enrolling by invitation |
NCT02757339 -
Evaluating the Neurobiological Basis of Traumatic Dissociation in Women With Histories of Abuse and Neglect
|
||
Active, not recruiting |
NCT01157416 -
Effect of D-cycloserine on Treatment of Posttraumatic Stress Disorder (PTSD) in Youth
|
Phase 2 | |
Completed |
NCT01208844 -
Study of Physical Health for Women With Posttraumatic Stress or Depression
|
N/A | |
Not yet recruiting |
NCT01914861 -
Cortisol Diurnal Variation and the Risk for Developing Post Traumatic Stress Disorder
|
N/A | |
Unknown status |
NCT01644851 -
Cognitive Training for Post Traumatic Stress Disorder: Effects on Cognitive, Emotional, and Brain Function
|
N/A | |
Completed |
NCT01896388 -
Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial
|
Phase 1/Phase 2 | |
Recruiting |
NCT01947725 -
Behavioral Activation for Smoking Cessation in Veterans With PTSD
|
N/A |